Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology
- Hemolytic disease of the fetus and newborn.Vox Sang. 2015; 109: 99-113
- Fetal anemia.Ultrasound Obstet Gynecol. 2017; 50: 145-153
- Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in The Netherlands, 1988-1999.Acta Obstet Gynecol Scand. 2004; 83: 731-737
- Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures.Ultrasound Obstet Gynecol. 2017; 50: 180-186
- Early intrauterine transfusion in severe red blood cell alloimmunization.Ultrasound Obstet Gynecol. 2010; 36: 601-606
- Management of very early fetal anemia resulting from red-cell alloimmunization before 20 weeks of gestation.Obstet Gynecol. 2011; 118: 1323-1329
- Intravenous fetal exchange transfusion before 22 weeks of gestation in early and severe red-cell fetomaternal alloimmunization.Fetal Diagn Ther. 2003; 18: 467-471
- Intraperitoneal transfusion in severe, early-onset Rh isoimmunization.Obstet Gynecol. 2007; 110: 880-884
- Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion.Fetal Diagn Ther. 2008; 23: 159-163
- High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.J Perinat Med. 1997; 25: 85-88
- IVIG–is it the answer? Maternal administration of immunoglobulin for severe fetal red blood cell alloimmunization during pregnancy: a case series.Aust N Z J Obstet Gynaecol. 2009; 49: 612-618
- Intravenous immune globulin in autoimmune and inflammatory diseases.N Engl J Med. 2012; 367: 2015-2025
- Fetal and neonatal alloimmune thrombocytopenia.Best Pract Res Clin Obstet Gynaecol. 2008; 22: 3-14
- High-dose intravenous IgG for the treatment of severe rhesus alloimmunization.Vox Sang. 1991; 61: 181-189
- Clinical uses of intravenous immunoglobulin in pregnancy.Clin Obstet Gynecol. 1999; 42: 368-380
- The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia.Am J Obstet Gynecol. 2005; 193: 1094-1099
- Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.Gynecol Obstet Invest. 2007; 63: 176-180
- Management of rhesus alloimmunization in pregnancy.Obstet Gynecol. 2002; 100: 600-611
- Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses.N Engl J Med. 2000; 342: 9-14
- Fetal hemoglobin measurement in the assessment of red cell isoimmunization.Lancet. 1988; 1: 1073-1075
- An introduction to propensity score methods for reducing the effects of confounding in observational studies.Multivariate Behav Res. 2011; 46: 399-424
- Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study.Am J Obstet Gynecol. 2012; 206: 141.e1-141.e8
- The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.Transfusion. 2013; 53: 777-782
- Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial.Pediatrics. 2011; 127: 680-686
- A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality.Pediatrics. 2007; 120: 27-32
- Comparing healthcare outcomes.BMJ. 1994; 308: 1493-1496
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.Stat Med. 2015; 34: 3661-3679
This research was supported by a grant from Sanquin Blood Supply (L2181). The design, conduct, or publication of the study was not influenced by this financial support.
The authors report no conflict of interest.
Cite this article as: Zwiers C, van der Bom JG, van Kamp IL, et al. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn. Am J Obstet Gynecol 2018;219:291.e1-9.